Literature DB >> 19471876

Lipid-based emulsion system as non-viral gene carriers.

Hae Yun Nam1, Jae Hyung Park, Kwangmeyung Kim, Ick Chan Kwon, Seo Young Jeong.   

Abstract

The genetic materials for systemic administration meet a number of hurdles before they reach the nucleus of the target cells, such as enzymatic degradation in the bloodstream, extravascularization around the target tissue, endocytosis by the target cells, and endosomal escape of the genes. Therefore, there have been tremendous needs of effective gene carriers that can deliver the genetic materials to the target site. Of numerous approaches, recent studies have demonstrated that the lipid-based emulsion systems have the high potential as non-viral gene carriers: 1 lipid emulsions are biocompatible because their major constituents are composed of the non-toxic oils and amphiphilic lipids; 2 the cationic lipid emulsions can form nano-sized complexes with negatively charged DNAs, through which the genetic materials can be protected from the enzymatic degradation in the body fluids; 3 The emulsion/DNA complexes are shown to be stable in the bloodstream since their surfaces are rarely recognized by the immune-related cells and serum proteins; and 4 the surfaces of the emulsion complexes are readily modified by varying the lipid composition. In this review, highlighted are the recent advances in the emulsion-based gene carriers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471876     DOI: 10.1007/s12272-009-1500-y

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  6 in total

Review 1.  Nanoemulsions as Gene Delivery in Mucopolysaccharidosis Type I-A Mini-Review.

Authors:  Paweł Zapolnik; Antoni Pyrkosz
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

2.  Influence of phospholipid composition on cationic emulsions/DNA complexes: physicochemical properties, cytotoxicity, and transfection on Hep G2 cells.

Authors:  Michelle Fraga; Fernanda Bruxel; Valeska Lizzi Lagranha; Helder Ferreira Teixeira; Ursula Matte
Journal:  Int J Nanomedicine       Date:  2011-10-07

3.  Factors influencing transfection efficiency of pIDUA/nanoemulsion complexes in a mucopolysaccharidosis type I murine model.

Authors:  Michelle Fraga; Talita Giacomet de Carvalho; Juliana Bidone; Roselena Silvestri Schuh; Ursula Matte; Helder Ferreira Teixeira
Journal:  Int J Nanomedicine       Date:  2017-03-15

Review 4.  ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes.

Authors:  Anna V Piterina; Aidan J Cloonan; Claire L Meaney; Laura M Davis; Anthony Callanan; Michael T Walsh; Tim M McGloughlin
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

5.  Physical factors affecting plasmid DNA compaction in stearylamine-containing nanoemulsions intended for gene delivery.

Authors:  André Leandro Silva; Francisco Alexandrino; Lourena Mafra Verissimo; Lucymara Fassarella Agnez-Lima; Lucila Carmem Monte Egito; Anselmo Gomes de Oliveira; Eryvaldo Socrates Tabosa do Egito
Journal:  Pharmaceuticals (Basel)       Date:  2012-06-18

Review 6.  Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.

Authors:  Alicia Rodríguez-Gascón; Ana del Pozo-Rodríguez; María Ángeles Solinís
Journal:  Int J Nanomedicine       Date:  2014-04-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.